Atlas Trials

A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer

Clinical trial NCT01740336 · COMPLETED

Trial details

NCT number
NCT01740336
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2013-02-06
Primary completion
2015-10-20
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.